Curing Hepatitis C: An update for primary care providers 23-June-2017 Webinar
- Teacher: Natalie Huska
Preparing patients for interferon free treatment
- Teacher: Melinda Hassall
This online learning
module consists of 4 individual modules covering; HCV epidemiology, prevention
and natural history; HCV testing and liver disease staging; Treatment options
for HCV; and Monitoring, adherence and post-treatment follow-up. These modules
are designed for medical practitioners working in drug and alcohol settings or
with people who inject drugs.
Comprehensive General Practice (GP) health care as well as specific HCV care is important for patients living with chronic HCV infection. This population has a high rate of morbidity and mortality from liver disease, injecting drug use (IDU) and other causes which are potentially treatable in a GP setting. There is evidence, from other health conditions, that the use of a comprehensive general practitioner management plan (GPMP) results in improved health outcomes.
The overall aim of the HCV GPMP Audit and Training is to address some of the issues in the management of HCV as a long-term condition and improve communication between general practitioners, HCV specialists and patients.
On completion of the HCV GPMP Audit and Training, GPs will be able to:
- Recognise the importance of hepatitis C (HCV) infection in Australia
- Assess the range of health needs for a patient living with chronic HCV
- Develop a comprehensive GP management plan based on the patient needs that follows national guidelines
- Increase effectiveness of communication with specialists and other health care providers
Five videos presented by leading clinicians in the sector addressing current issues in hepatitis C management. These short videos cover new therapies, assessment with fibroscan, cirrhosis and transplantation, co-infection and up to date epidemiological information for Australia.
Target audience: General practitioners, infectious diseases physicians and gastroenterologists.
CPD: RACGP 3 Category 2 QI&CPD points.
Type: Videos (2014)
Funded by: Abbvie - unconditional educational grant.
This course was developed by ASHM in collaboration with the Australasian Chapter of Addiction Medicine.
Target audience: AChAM Fellows and other Drug and Alcohol practitioners.
Upon completion of the 3 case-based modules, participants will be able to:
- Explain the natural history of hepatitis C virus and describe which factors may be involved in more rapid disease progression
- Evaluate who should be tested for HCV and describe the tests involved in confirming chronic HCV infection and baseline assessment
- Assess people living with chronic HCV and provide appropriate advice / management strategies to improve their quality of life
- Provide advice on treatment options for chronic HCV and refer appropriately for specialist assessment
- Recognise signs and symptoms of chronic liver disease and indications for specialist referral
- Describe when to monitor treatment response and when dose reduction or treatment cessation may be needed